TMCI:NASDAQ
Treace Medical Concepts, Inc
$4.31
arrow_downward
-0.92%(-0.040) 1D
$4.31
0.00% (0.00)
bedtimeAfter hours
Closed: Nov 20, 4:00:01 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for TMCI...
Open
$4.31
High
$4.43
Low
$4.17
Mkt. cap
282.56M
Avg. vol.
288.65K
Volume
232.76K
52-wk high
$5.43
52-wk low
$1.17
EPS
-$0.86
Beta
1.59
Shares outstanding
65.56M
No. of employees
450
Open
$4.31
High
$4.43
Low
$4.17
Mkt. cap
282.56M
Avg. vol.
288.65K
Volume
232.76K
52-wk high
$5.43
52-wk low
$1.17
EPS
-$0.86
Beta
1.59
Shares outstanding
65.56M
No. of employees
450
News stories
From web sources and news partners
The Motley Fool
·
1 hour ago
The S&P 500 Is 14 for 14 After Midterm Elections. Here’s How I’d Invest Now.
Yahoo Finance
·
1 day ago
Chips suffer worst week since 2001 as the Nasdaq nears a bear market
Profile
Treace Medical Concepts, Inc. is a medical device company, headquartered in Ponte Vedra Beach, Florida, specializing in the design, manufacture, and marketing of foot and ankle surgical devices and biologics. Lapiplasty, Treace’s novel primary surgical product, advanced the treatment of bunions, surgically correcting the metatarsal bone, for the first time, in all three dimensions.
In March 2021, Treace announced its intent to launch an initial public offering. Trading on the Nasdaq under the ticker symbol “TMCI”, Treace opened its IPO in April 2021. Wikipedia
About Treace Medical Concepts, Inc